RENAE VAUGHN: Open Payments
NPI 1518923093 · PALM COAST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 10 payments from 8 companies in 2025. Trend: 2023 $234 · 2024 $409 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| TAIHO ONCOLOGY, INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: OPDIVO, FRUZAQLA, Nubeqa, BLENREP, RYBREVANT, MONJUVI, LONSURF, OJJAARA.
Industry payments across FL — which companies pay providers there.
